Promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy
Crossref DOI link: https://doi.org/10.1007/s00535-024-02111-0
Published Online: 2024-05-04
Published Print: 2024-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chiba, Mitsuro https://orcid.org/0000-0001-6382-0047
Kimura, Kazuya
Text and Data Mining valid from 2024-05-04
Version of Record valid from 2024-05-04
Article History
Received: 23 April 2024
Accepted: 25 April 2024
First Online: 4 May 2024
Declarations
:
: The authors declare that they have no conflict of interest.